EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES IN NEW YORK STATE
$1,660,174,558
AI Summary
This $1.7 billion cooperative agreement from HHS funds epidemiology and laboratory capacity in New York State for preventing and controlling emerging infectious diseases. The program strengthens the state's public health infrastructure, including disease surveillance systems, laboratory testing capabilities, and outbreak response.
Key Points
- 01Funded at approximately $1.7 billion through the ELC program
- 02Supports infectious disease prevention and control in New York State
- 03Active from August 2019 through July 2027
- 04Administered through Health Research, Inc. on behalf of New York State
- 05Strengthens epidemiology and laboratory capacity statewide
Award Details
Official Source
View on USAspending.govAd Space (inline)
Related Awards
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF
$51.2B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseAug 1, 2016
OtherHealthcare
IGF::OT::IGF MANAGED CARE SUPPORT SERVICES IN SUPPORT OF THE TRICARE PROGRAM
$23.5B
HEALTH NET FEDERAL SERVICES, LLC
Department of DefenseFeb 1, 2023
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION EAST REGION
$5.3B
HUMANA GOVERNMENT BUSINESS INC
Department of DefenseJan 1, 2024
OtherHealthcare
TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION WEST REGION
$4.4B
TRIWEST HEALTHCARE ALLIANCE CORP
Quick Summary
- Amount
- $1.7B
- Agency
- Department of Health and Human Services
- Recipient
- HEALTH RESEARCH, INC.
- Type
- Other
From the Civic Digest Network
Ad Space (rectangle)